Clinical Trials Directory

Trials / Unknown

UnknownNCT00310739

Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
Sponsor
Hamamatsu University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat. The purpose of this clinical study is to test whether the changes of human urinary excretion of MDA, and can be used as early biomarker for the prediction of development of CDDP-induced ARF.

Conditions

Timeline

First posted
2006-04-04
Last updated
2006-11-07

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00310739. Inclusion in this directory is not an endorsement.